Nyxoah (NASDAQ:NYXH) used its fourth-quarter and full-year 2025 earnings call to outline the first results from the U.S. launch of its Genio hypoglossal nerve stimulation system, discuss the evolving ...
DAKAR, Senegal — Sitting at an upscale hotel in Senegal ‘s capital, the young man seemed nervous, rarely making eye contact ...
Medicaid expansion remains a critical source of coverage for people with low incomes, many of whom lack access to affordable health coverage through other sources. In the ten remaining non-expansion ...
CMS accepting comments on data collection requirements for Medicare Advantage plans, Part D sponsors
The Centers for Medicare & Medicaid Services is seeking comments by May 11 on its proposed revisions to data reporting requirements for Medicare Advantage and Part D plans, according to a Paperwork ...
A warrantless wiretapping law known as Section 702 is set to expire on April 20 unless Congress votes to extend it. Past ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results